Loading…
Reported covered position: Chief of Staff-Rep. Robin Kelly (D-IL), Policy Dir.-Cong. Black Caucus/Rep. Emanuel Cleaver II (D-MO), Leg. Dir.-Rep. Marcia Fudge (D-OH); and Leg. Asst.-Rep. Wm. Jefferson (D-LA).
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Biosimilars Access and Affordability Act
Client: AMGEN INC. · Firm: EMPIRE CONSULTING GROUP
HR 10628, Biosimilars Access and Affordability
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BUSINESS ROUNDTABLE via EMPIRE CONSULTING GROUP
2026 · third_quarter · RR
Issues pertaining to economic policies and American competitiveness.
KALSHI INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · RR
Source: Senate LDA
| WALMART INC |
| 15 |
| 2021–2024 |
| GILEAD SCIENCES, INC. | 14 | 2023–2026 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 14 | 2023–2026 |
| VERTEX PHARMACEUTICALS INCORPORATED | 13 | 2023–2026 |
| CISCO SYSTEMS, INC. | 12 | 2024–2026 |
| EXXON MOBIL CORP | 12 | 2024–2026 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 11 | 2024–2026 |
| BLACKROCK FUNDS SERVICES GROUP, LLC | 10 | 2024–2026 |
| REWORLD WASTE, LLC | 8 | 2025–2026 |
| TURO | 8 | 2025–2026 |
| FRANCIS ENERGY | 7 | 2023–2024 |
| HOTWIRE COMMUNICATIONS LTD. | 7 | 2024–2025 |
| TRANSIT LABS | 7 | 2022–2024 |
| CTIA | 6 | 2025–2026 |
| MANAGED FUNDS ASSOCIATION | 6 | 2021–2022 |
| AMERICAN BANKERS ASSOCIATION | 5 | 2025–2026 |
| AMGEN, INC. | 5 | 2025–2026 |
| CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) | 4 | 2025–2026 |
| MIAMI-DADE COUNTY | 4 | 2024 |
| WEST REALM SHIRES SERVICES INC. D/B/A FTX US | 4 | 2022 |
| BOEING COMPANY | 3 | 2025–2026 |
| MEHARRY MEDICAL COLLEGE | 3 | 2021 |
| BUSINESS ROUNDTABLE | 1 | 2026 |
| CONSTELLATION BRANDS, INC | 1 | 2023 |
| KALSHI INC. | 1 | 2026 |
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues related to Kidney health, HR 1227 Alternatives to Pain Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 1227, Alternatives to Pain Act
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
HR 2784-Stopping Theft and Destruction of Broadband Act
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Main Street Capital Access Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
H.R. 6955 Main Street Capital Access Act and the ROAD Act.
Recycled Materials Attribution Act of 2026
Client: EXXON MOBIL CORP. · Firm: EMPIRE CONSULTING GROUP
HR 7502-Recycled Materials Attribution Act (RMAA).
Recycled Materials Attribution Act of 2026
Client: EXXON MOBIL CORP. · Firm: EMPIRE CONSULTING GROUP
HR 7502-Recycled Materials Attribution Act (RMAA).
Farm, Food, and National Security Act of 2026
Client: THE COCA-COLA COMPANY · Firm: EMPIRE CONSULTING GROUP
Issues related to the Food, Farm and National Security Act of 2026 (HR 7567).
Issues related to HR 8870, Build America 250 Act.
Tax Exempt Hospital Transparency Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.
10 Percent Credit Card Interest Rate Cap Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
S.381, 10 Percent Credit Card Interest Rate Cap Act. SCAM Act. Main Street Community Banking.
10 Percent Credit Card Interest Rate Cap Act
Client: AMERICAN BANKERS ASSOCIATION · Firm: EMPIRE CONSULTING GROUP
Issues related to the Financial Stability Oversight Council. S.381-10 Percent Credit Card Interest Rate Cap Act. The Road Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act; issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 1227, Alternatives to PAIN Act.
Stopping the Theft and Destruction of Broadband Act of 2025
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HR 235-Triple Negative Breast Cancer Research & Education. Clinical trial results for Lenacapavir.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to Gilead Sciences' drug portfolio. HR 235-Triple Negative Breast Cancer Research & Education.
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing. PDUFA. Health Access & Equity. Pharmacy Benefit Manager Reform Act. 340B. Supplemental funding.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act. Issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. FY 2025 Appropriations Act. S.3832-Alternative to PAIN Act. S.127-Pharmacy Benefits Manager Transparency Act. Health equity/disparities.
Pharmacy Benefit Manager Transparency Act of 2023
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
HR 7142, Alternatives to PAIN Act. S.127, Pharmacy Benefits Manager Transparency Act. Issues related to CMMIs Cell and Gene Therapy Access model for Sickle Cell Disease.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: EMPIRE CONSULTING GROUP
Issues pertaining to cell and gene therapy. FY 2025 Appropriations Act. S.3832-Alternative to PAIN Act. S.127-Pharmacy Benefits Manager Transparency Act. Health equity/disparities.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. WH Cancer Moonshot program. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. HIV/AIDS funding. HR 235 Triple Negative Breast Cancer Research & Education. 340B.
Triple-Negative Breast Cancer Research and Education Act of 2023
Client: GILEAD SCIENCES INC. · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to Gilead Sciences' drug portfolio. WH Cancer Moonshot program. HIV/AIDS funding. HR 235, Triple Negative Breast Cancer Research & Education
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing.
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858, No Free TRIPS Act. Issues related to drug pricing. PDUFA. Health Access & Equity. Pharmacy Benefit Manager Reform Act. 340B
No Free TRIPS Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: EMPIRE CONSULTING GROUP
Inflation Reduction Act. Issues related to insulin. HR 3858 No Free TRIPS Act.
Issues related to commercial banking. Senate Oversight Hearing on SEC. S.2860, the Safer Banking Act. Issues Pertaining to Artificial Intelligence.
American Data Privacy and Protection Act
Client: CHARTER COMMUNICATIONS INC. · Firm: EMPIRE CONSULTING GROUP
Issues related to broadband policy; Inflation Reduction Act; and HR 8152, the American Data Privacy & Protection Act.
Online Retailer Product Origin Disclosure Act
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding S.1260, The United States Innovation and Competition Act, and HR 4001, related to the enforcement of country-of-origin labeling on product listing pages.
Expanding Medical Education Act
Client: MEHARRY MEDICAL COLLEGE · Firm: EMPIRE CONSULTING GROUP
Issues related to funding of Historically Black Colleges; HR 801-Expanding Medical Education Act; and issues pertaining to COVID-19.
Expanding Medical Education Act
Client: MEHARRY MEDICAL COLLEGE · Firm: EMPIRE CONSULTING GROUP
Issues related to funding of Historically Black Colleges & Universities; HR 801-Expanding Medical Education Act; health disparities among minority populations; issues pertaining to COVID-19; and Budget Reconciliation provisions affecting client.
United States Innovation and Competition Act of 2021
Client: WALMART INC. · Firm: EMPIRE CONSULTING GROUP
Discussions regarding S.1260, The United States Innovation and Competition Act, and HR 4001, related to the enforcement of country-of-origin labeling on product listing pages.
Issues related to prediction markets and finance.
Issues related to prediction markets and finance.
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to energy infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the Farm Bill and the food and beverage industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to surface transportation reauthorization bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
H.R. 6955 Main Street Capital Access Act and the ROAD Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the environment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 7502-Recycled Materials Attribution Act (RMAA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to AI, and the NDAA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Kidney health, HR 1227 Alternatives to Pain Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
NDAA. Issues related to wireless policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to health policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 10628, Biosimilars Access and Affordability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
HR 2784-Stopping Theft and Destruction of Broadband Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to Name Image Likeness (NIL), and the operational performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to the aviation and trucking industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
Issues related to carriage agreements, and Section 815 NDAA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · third_quarter · Q3
MFN drug pricing, 340B, PBM reform, and other drug pricing issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the Food, Farm and National Security Act of 2026 (HR 7567).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to triple negative breast cancer treatment. Issues related to health access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 8870, Build America 250 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
S.381, 10 Percent Credit Card Interest Rate Cap Act. SCAM Act. Main Street Community Banking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues relating to waste management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to data centers/infrastructure.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
HR 7502-Recycled Materials Attribution Act (RMAA).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to Artificial Intelligence, NDAA and Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 1227, Alternatives to Pain Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the wireless industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to health access. PBM reform. Most Favored Nation issues. 340B Reform. Issues related to Womens Health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to sports and fitness.
Issues related to NIL.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to the trucking industry and aviation industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · second_quarter · Q2
Issues related to disaster resilience technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Surface Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the Financial Stability Oversight Council. S.381-10 Percent Credit Card Interest Rate Cap Act. The Road Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to higher education. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues relating to sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to retirement and infrastructure. Issues related to public utilities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Advanced recycling. Issues related to the EU's Corporate Sustainability Due Diligence Directive.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Artificial Intelligence. National Defense Authorization Act (NDAA). Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
HR 1227, Alternatives to PAIN Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to aviation and defense. Defense Appropriations FY 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the wireless industry. Government funding. Advancing American WiFi Against Adversaries Act. Issues related to Artificial Intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the food and beverage industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to health access. Issues related to HIV medication.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to health access. PBM reform. Most-Favored-Nation pricing for pharmaceuticals. 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to footwear and sport and health/fitness.
Issues related to the SCORE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the trucking industry and aviation. Government funding. Surface Reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
PBM reform. Issues related to health access. 340B reform issues. Issues related to Most-Favored-Nation prescription drug pricing. Tariffs on pharmaceutical products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2026 · first_quarter · Q1
Government funding. NTSB/DCA accident. ROTOR Act. Operational and performance issues for AAL. Issues related to DHS.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the food and beverage industry
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to HR 2784-Stopping Theft and Destruction of Broadband Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Surface Reauthorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues relating to sustainability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to retirement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Advanced recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Artificial Intelligence. National Defense Authorization Act (NDAA). Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
HR 1227, Alternatives to PAIN Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the commercial banking industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to aviation and defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the wireless industry. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to health access. Issues related to HIV medication.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to health access. PBM reform. Most-Favored-Nation pricing for pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the SCORE Act.
Issues related to footwear and sports.
Filing targets: HOUSE OF REPRESENTATIVES
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the trucking industry and aviation. Government funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
PBM reform. Issues related to health access. 340B reform issues. Issues related to Most-Favored-Nation prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2025 · fourth_quarter · Q4
Government funding. NTSB hearing. ROTOR Act. Operational and performance issues for AAL.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2025 · third_quarter · RA
Issues related to transportation matters.
TURO via EMPIRE CONSULTING GROUP
2025 · third_quarter · 3A
issues related to transportation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
issues related to transportation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TURO via EMPIRE CONSULTING GROUP
2025 · third_quarter · RR
Issues related to transportation matters.
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to banking and financial services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALIFORNIA STATE UNIVERSITY, SACRAMENTO (SACRAMENTO STATE) via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REWORLD WASTE, LLC via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues relating to sustainability, the environment, and financial services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLACKROCK FUNDS SERVICES GROUP, LLC via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to financial services, retirement, and taxation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORP. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the oil & gas industry. Issues related to advanced recycling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CISCO SYSTEMS, INC. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
2026 National Defense Authorization Act (NDAA). The Safe Supply Chains Act. Issues related to international relations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOTWIRE COMMUNICATIONS, LTD. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
HR 1227, Alternatives to PAIN Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to commercial banking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to commercial aviation and defense.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the wireless industry. Issues related to innovative wireless technological solutions for American communities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the Supplemental Nutrition Assistance Program (SNAP). Issues related to food safety and ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES INC. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
PBM reform. PEPFAR funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to PBM reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARTER COMMUNICATIONS INC. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIKE, INC. via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Proposals and issues related to health, sports, and fitness, and the economic, operational, and management performance of Nike.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDEX CORPORATION via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the trucking and aviation industries. Issues related to the disclosure of aircraft, rail, and vehicle information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Issues related to the telecommunications industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Pharmacy Benefit Manager Reform. Issues related to 340B. Most-Favored-Nation prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN AIRLINES INC via EMPIRE CONSULTING GROUP
2025 · third_quarter · Q3
Safety issues at DCA pertaining to military aircraft & commercial aviation. ATA reform/modernization. Issues related to the economic, operational, and management performance of American Airlines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN BANKERS ASSOCIATION via EMPIRE CONSULTING GROUP
2025 · third_quarter · RR
Issues relating to banking and financial services.
Issues relating to banking and financial services.